Advanced Wound Care Summit US 2023
2023-07-12 - 2023-07-13 | Boston, Massachusetts
The Advanced Wound Care Summit is wound care’s only industry-led forum
It’s a chance for senior executives to address shared challenges around innovative product development, build meaningful partnerships, and sharpen their R&D and commercial strategies.
Whether an established wound care company, an emerging startup, an SME, a regulator, a payer, or key opinion leader, this event serves your strategic and commercial goals.
To take this chance to uncover how leading figures are leveraging novel clinical trial designs, addressing reimbursement challenges surrounding skin substitute products, progressing next generation diagnostic innovations, and much more.
To know more visit: https://hubs.ly/Q01J-t480

3rd Tumor Myeloid-Directed Therapies Summit
2023-07-18 - 2023-07-20 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
The 3rd Annual Tumor Myeloid-Directed Therapies Summit returns with over 75% new speakers to share insights across a range of myeloid targets, including CD40, CD39, LILRB2, CLEC-1 as well as CAR-M therapies. The one-stop shop continues to be your go-to forum to accelerate myeloid therapy progression by determining optimal combination strategy, optimize translational studies, discover novel targets, and guarantee patient safety. Connect with this up-and-coming community to reinvent targeting and harness the untapped potential of the myeloid.
Collaborate and learn from myeloid experts across industry and academia over 3 in-depth days of content, as they address the key bottlenecks limiting the efficacy and safety of these exciting treatments, including in vivo models, biomarkers of response, combination rationale, and myeloid biology to accelerate myeloid directed therapies.
To know more visit: https://ter.li/tm1bzy

ADC Toxicity Summit
2023-07-25 - 2023-07-27 | Hyatt Regency Boston Downtown, One Ave. de Lafayette, Boston, MA, 02111, United States
There is a vast number of ADCs that never make it to the clinic let alone to market, and this is largely due to toxicological challenges providing a narrow therapeutic index. Understanding the causes of toxicity, their translatability into the clinic, as well as mitigation and dosing strategies to limit these toxicities will enable ADC developers to take more assets into the clinic while reducing the costs of failures.
The inaugural ADC Toxicity Summit is coming to Boston, MA this July 25-27 as the first and only meeting dedicated to enabling drug developers to analyze mechanisms of action, discuss shared challenges associated with translating in vivo toxicity data to the clinic, and optimizing dosing to minimize the toxicity of your drug and improve tolerability to bring more ADCs with a wider therapeutic index to market.
Take a look at our 3-day event guide for your in-depth roadmap to the ADC Toxicity Summit.
Uniting all key stakeholders invested in this conversation ranging from toxicologist and pathologists, through to nonclinical, translational, and clinical experts, this is your exclusive opportunity to harness never before gained insights to deliver a safer and more tolerable generation of ADCs to patients.
3 reasons why you can’t miss out on joining include:

Select optimal preclinical models for determining ADC toxicity profiles to enable improved translatability and ultimately improve clinical trial outcomes with Seagen and AbbVie
Hear how companies with commercially approved ADCs mitigated toxicities in the clinic, and optimized their dosage allowing expansion of their therapeutic windows with ImmunoGen and the Dana Farber Cancer Institute
Uncover ideal linker stability and drug-antibody ratios to design an ADC with a lower toxicity profile with Bristol Myers Squibb, Iksuda and Merck & Co

Harnessing case-study led presentations and interactive discussions to enable you to select optimal models for your GLP toxicity studies, mitigate ADC related toxicities in the clinic and optimize linker-design for more controlled payload release, this is your exclusive opportunity to harness new insights to minimize the toxicity of your drug.

2nd Annual Targeted Radiopharmaceuticals Summit
2023-07-25 - 2023-07-27 | Westin Boston Seaport, 425 Summer Street, Boston, MA, 02210, United States
With the exciting news that Novartis has received US FDA approval for Pluvicto for previously-treated patients with PSMA-positive metastatic castration-resistant prostate cancer, the TRP space is continuing to go from strength to strength.
This is why the upcoming 2nd Annual Targeted Radiopharmaceuticals Summit US program is even more comprehensive than ever, bringing you a tracked agenda covering the whole TRP landscape from discovery, translation, to clinical, late stage progress and challenges – a unique opportunity for your entire team to learn and network.
Join us to:

Explore the novel target selection to re-route targeted radiopharmaceuticals from a niche-label therapeutic
Navigate the regulation and reimbursement challenges to improve the accessibility of targeted radiopharmaceuticals
Review theragnostic in the clinic to exploit the two-birds-one-stone potential of TRPs
Discover the potential combination therapies with DDRi’s and IO to unlock synergy with other modalities
Harness the platform technologies for optimized preclinical evaluation of drugs

All presented by top industry players such as Clarity Pharmaceuticals, SOFIE Biosciences, Lantheus, Fusion Pharmaceuticals, Rayze Bio, Telix Pharmaceuticals, OranoMed, Actinium Pharmaceuticals, and many more.
Download the brand-new event guide here to see a full overview 3-day content and speaker faculty: https://ter.li/8hn0z2

Fusion Protein Engineering & Developability Summit
2023-07-25 - 2023-07-27 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
Design & Engineer Functional & Manufacturable Novel Fusion Proteins
Prepare to be captivated by the Fusion Protein Engineering & Developability Summit, the ultimate event tailored to drug developers with groundbreaking fusion protein pipelines. This conference is an absolute game-changer that should be at the top of your priority list!
As the demand for practical and effective engineering techniques to expedite the development of viable drugs into clinical applications skyrockets, this highly anticipated summit offers an unrivalled opportunity. Join forces with esteemed experts from industry giants like Roche, Merck, Bristol Myers Squibb, Abbvie, and an array of other distinguished names. Seize this unique occasion to connect with fellow drug developers, exchange innovative ideas and strategies, and gain invaluable insights into cutting-edge fusion applications.
Prepare for a whirlwind of activity across the action-packed three-day agenda, including:

Cutting-Edge Insights: Gain exclusive access to the latest breakthroughs in fusion protein engineering, encompassing the most recent research and emerging trends in this dynamic field.
Practical Learning: Immerse yourself in hands-on workshops led by industry experts, designed to enhance your skills and knowledge in must-know areas.
Real-World Case Studies: Immerse yourself in over 17+ data-driven case studies presented by renowned drug developers, offering profound insights and best practices.
Engaging Discussions: Engage in lively panel discussions and roundtable sessions, fostering debates and knowledge exchange on hot topics such as novel linker selection and the identification of PK/PD rules.
Networking Opportunities: Forge valuable connections with 60+ protein engineers, therapeutic developers, and influential industry leaders during 7+ hours of dedicated networking, including the renowned speed networking session.

With a stellar lineup of 25+ speakers, 3 immersive hands-on workshops, and 2 days packed with data-driven case studies, this event is set to become the unequivocal highlight of the year and you cannot afford to miss it!
To know more visit: https://ter.li/uuyrdu

4th Gamma Delta T Therapies Summit
2023-07-25 - 2023-07-27 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Established industry leaders and emerging innovators such as Adicet Bio, IN8Bio, Sanofi, Merck, LAVA Therapeutics, Takeda and Leucid Bio are driving the race to demonstrate the potential of Gamma Delta T Therapies as cytotoxic, off-the-shelf solid tumor therapies, spurred by early indications of clinical efficacy.
The 4th Gamma Delta T Therapies Summit returns to Boston this July as the ultimate Industry-focused forum to advance your Gamma Delta T research, spanning dedicated 2 tracks of content to maximize your Clinical & Product Optimization and Research & Translational Development. Join 150+ expert industry peers for 2 full days of sessions and a pre-conference workshop and deep-dive day, building on early clinical successes, highlighting process and engineering innovations and leveraging early clinical insights to cast the spotlight onto Gamma Delta T Therapies in the clinic.
To know more visit: https://ter.li/69o2yc

3rd mRNA-Based Therapeutics Summit
2023-07-26 - 2023-07-28 | The Westin Boston Seaport District, 425 Summer Street, Boston, MA, 02210, United States
The 3rd mRNA-Based Therapeutics Summit returns to Boston this July, cementing its position as the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.
Download the event program here.
This year’s meeting promises 75+ deep-dive case studies from a speaker faculty that is 85% new for this year’s agenda, featuring presentations from the FDA, Pfizer, Moderna, BioNTech, Sanofi and many more.

Expect 100+ world-class speakers from large pharma, innovative biotechs, and key opinion leaders of academia, 5 dedicated tracks and 3 days of immersive content on discovery, translation, clinical development, chemistry, manufacturing and controls (CMC) and logistics to overcome industry hurdles of optimized dosing, targeted delivery, safety and scalability to achieve regulatory success in infectious and rare diseases, cancer and beyond!
Register your team here to join 500+ mRNA experts in July.

2nd ADC Linker & Conjugation 2023
2023-08-22 - 2023-08-24 | Wyndham Boston Beacon Hill, 5 Blossom St, Boston, MA, 02114, United States
Investments in linker and conjugation technologies have become the single-biggest area of investments within the ADC field, showing how they are being used as key levers for ADC drug developers to pull to create ADCs with a widened therapeutic index.
The inaugural ADC Linker & Conjugation Summit has been specifically designed to drive innovations in linker and conjugation chemistries that result in stable ADCs, with low aggregation and controlled release, which can be replicated at scale.
See the complete event guide here.
Here’s a snapshot of our speaker faculty, including expert industry leaders such as:

Sayumi Yamazoe, Senior Principal Scientist, Bristol Myers Squibb
Romas Kudirka, Director, Chemistry & Bioconjugation, Bolt Biotherapeutics
Donglu Zhang, Senior Fellow, Genentech
Paul Song, Chief Scientific Officer, Genequantum
Patrick Higgs, Principal Scientist, Chemistry, Iksuda
Noah Bindman, Principal Scientist, Seagen
Marc-André Kasper, Director, Chemistry & Early Discovery, Tubulis
Paul Sauter, Director, Chemistry, VERAXA

…and many more!
Find the full list of speakers and session details here.
Be part of the first industry-dedicated meeting for professionals just like you, interested in learning about developments in the field of ADC linkers and conjugations, and overcoming common challenges with stability.

RNA Assay Development & Screening Summit
2023-08-23 - 2023-08-24 | The Bostonian Boston, 26 NORTH STREET, BOSTON, MA, 02109, United States
Bringing together technical experts from biopharma and academia, the brand-new RNA Assay Development & Screening Summit has been curated to support in-house assay development and screening strategies to find new RNA targets, and ultimately determine biological effect in a manner that supports progression from early discovery to drug candidate.
Developed in collaboration with experts in the field, join 60+ key opinion leaders from the likes of Arrakis Therapeutics, Expansion Therapeutics and NextRNA at the first technical RNA meeting of its kind!
Come away with actionable insights after deep diving into the latest technical expertise and explore learnings from data-driven case studies.
Don’t miss this unique opportunity expand and validate your assay and screening strategies and accelerate the path to the clinic! Learn more – https://ter.li/8fsu01

8th CAR-TCR Summit
2023-08-29 - 2023-09-01 | Hynes Convention Center, 900 Boylston St, Boston, MA, 02115, United States
Last year was momentous for the cell therapy field: it was the year that CAR-T therapies became CURATIVE.
This decade of success has resulted in explosive investment into the development of CAR and TCR based approaches to ensure more patients around the world can benefit from these lifesaving therapies.
The 8th CAR-TCR Summit is returning to Boston as the industry’s trusted, definitive, end-to-end forum for the global network of autologous and allogeneic cell therapy drug developers. Ensure your whole team stays ahead of the curve with unmatched industry insights shared across discovery through to commercialization.
Across 3 conference days with 8 content tracks, and an additional 6 deep-dive workshops, bootcamp, focus day, diversity session, C-level think tank and more, 200+ CAR and TCR experts will lead you and over 1,000 peers in discussions that will accelerate your pipeline, bringing better drugs to patients faster.
To know more visit: https://ter.li/ztgick

2nd Oligonucleotides CMC & Analytical Development Summit 2023
2023-08-29 - 2023-08-31 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Rapid development and rising demand of oligonucleotide drugs is fuelling revolutionary steps in biopharma investment and technology advancement for pipeline progression. The prospect of defining impurities and suitable CQAs for long-term scalable manufacturing looks to propel oligonucleotide development to patients at a much faster rate.
The 2nd Oligonucleotides CMC & Analytical Development Summit returns this August to Boston. 70+ industry leaders will unite at this unique forum dedicated to CMC and Analytical Experts.
Across 3 days, senior leaders will leverage knowledge and share thought leadership focused on improving analytical characterization, effectively preparing CMC data for IND filing and scaling up with long-term manufacturing in mind.
Built with experts from AstraZeneca, Alexion Pharmaceuticals, Biogen , revolutionize your drug development protocols by keeping your finger on the pulse at this hotly anticipated summit.

Explore analytical control strategies for therapeutic oligonucleotides to ensure safety and quality with regulatory compliance
Overcome the challenges of capacity when out-sourcing to propel and expedite oligonucleotide development
Get interactive in roundtable discussions, picking the brains of your peers and expert speakers on how biopharma is currently navigating the regulatory landscape
Facilitate cost-efficient large-scale production of oligonucleotides now we are moving into larger patient populations and non-rare disease indications
Turbocharge novel and complex oligonucleotide development in an in-depth workshop outlining CMC, Analytical Characterization and Impurity Control of conjugates

Download your Full Event Guide Here for more details on what you can expect at the 2nd Oligonucleotides CMC & Analytical Development Summit. Including the expert speaker faculty, a full in-depth agenda and the incredible networking and collaboration opportunities on offer this year.

3rd Inner Ear Disorders Therapeutics Summit
2023-08-29 - 2023-08-31 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The development of next-generation drug-based approaches to treat inner ear disorders is gaining momentum, with multiple INDs approved in the last six months and big pharma making plays to acquire innovative biotechs working on hearing loss.
However, in a space that has also had to battle with multiple clinical failures, there’s a genuine need for the industry to unite and overcome the specific obstacles that are currently acting as a barrier to late-stage clinical trials and through to approval.
That’s why the 3rd Inner Ear Disorders Therapeutics Summit is back this summer, bringing together the community to collectively accelerate development of drug-based approaches, sharing case studies and data-driven insights into optimizing preclinical programs and designing translational studies to ultimately validate clinically relevant targets.
This meeting will leverage the latest biotech and academic innovation alongside big pharma experience to address the technical and strategic challenges in delivering a safe and effective therapy to the inner ear.
What to expect from the 2023 meeting:

Explore how to improve clinical trial design to increase the number of clinical trials achieving regulatory approval
Delve into the numerous delivery methods being employed in industry and explore how to optimize delivery to the inner ear
Evaluate the current opportunities and limitations of using animal models to accurately predict preclinical efficacy and translational success
Leverage valuable insights from VC investors to understand the key considerations made when investing in or forging partnerships with biotechs focussing on inner ear disorder therapeutics
Navigate the complex landscape of improving the diagnostics of inner ear disorders by developing a robust diagnostic toolbox and strategizing how to supplement patient-reported outcome measures

View the full agenda here: https://ter.li/a2ivra

5th Exosomes Based Therapeutic Development Summit
2023-09-05 - 2023-09-07 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
The 5th Exosome Based Therapeutic Development Summit returns with a refreshed program, with data-driven insights from those pioneering the field who are dedicated to the clinical translation and commercialization of exosome-based therapeutics across a broad range of disease indications.
This year features a brand-new focus day on analytical development, diving into characterization assays, purification, and potency assays to enable robust translation into the clinic.
This is the most comprehensive, end-to-end meeting for industry personnel who are looking to fine-tune molecular components of exosomes, achieve GMP manufacturing of EVs for clinical applications, and successfully deliver payloads to the target tissue by evaluating route of administration to accelerate candidates towards commercialization.
The 2023 conference covers:

Emerging standardized analytical strategies for optimized characterization, purification, and isolation to improve batch consistency and reproducibility towards successful scale-up
Key pre-clinical and clinical updates across a range of therapeutic areas
The latest advancements of targeted delivery and therapeutic payloads
The challenges of large-scale manufacturing
Navigating the complex regulatory landscape across the drug development timeline

View the full agenda here: https://ter.li/q4fnpd

4th Annual Gene Therapy Immunogenicity Summit 2023
2023-09-05 - 2023-09-07 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The 4th Annual Gene Therapy Immunogenicity Summit is your opportunity to connect with likeminded peers from gene therapy drug developers, along with leading academics, regulators, and key service providers, all making strides with improving risk assessments, monitoring, and mitigating against AAV gene therapy immunogenicity.
Registering for 2023 will grant you access to keynote plenaries from leading gene therapy figures, deep-dive discussions into pressing preclinical and clinical developments, and highly appraised networking opportunities with 150+ of your peers, all to leave you with the actionable tools, insights, and connections you need to enhance your immunogenicity-focused work.
To know more visit: https://ter.li/vk8xwq

13th World Clinical Biomarkers & CDx Boston 2023
2023-09-05 - 2023-09-08 | Omni Boston Hotel at the Seaport, 450 Summer Street, Boston, MA, 02210, United States
The hotly anticipated 13th World Clinical Biomarkers & CDx Summit returns as the only industry-led meeting uniting 600+ senior decision makers in the biomarker and CDx field to accelerate clinically validated and affordable co-development of drug-CDx by overcoming commercialization, reimbursement and regulatory challenges in oncology and beyond to bring personalized medicine to patients faster.
Whether you are working in Oncology, NASH, or Neuroscience, join 600+ Directors, Heads and VPs of Clinical Biomarkers, Translational Medicine, Precision Medicine & Companion Diagnostics together with drug and diagnostic developers, regulatory experts, payors and notified bodies for an exclusive opportunity of knowledge sharing and networking to propel your pipelines and make a marked difference for patient outcomes.
To know more visit: https://ter.li/849j6q

7th Complement-Based Drug Development Summit
2023-09-11 - 2023-09-13 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
With the recent FDA approval of SYFOVRE and more decisions and approvals expected in 2023, the Complement-Based Drug Development Summit is returning for its 7th year in a timely fashion. Be the first to view this year’s Event Guide below!
7th Complement-Based Drug Development Summit
September 11-13, 2023
View Agenda
Reuniting experts across Nephrology, Neurology, Ophthalmology, and Haematology, join the leading companies showcasing the latest preclinical and clinical progress for complement-based therapeutics.

With 30+ expert speakers from: AGTC, Alexion, Alnylam, Amgen, Annexon, Apellis – and that’s just the A’s!
Covering more complement targets than ever before including C5aR2, Factor Bb and Combination Therapy, alongside an increased coverage of diseases
Full of content for your whole team covering the most pressing challenges – from evaluating the value proposition of different fragments to target to designing clinical trials with high-risk patient populations

​​​​View the full list of sessions and expert speakers here.
​​​​​​This world-class speaker faculty will evaluate the entirety of the complement landscape, from scientific understanding to strategic, commercial intelligence. This means that no matter your role in the field, you’ll leave with tangible insights to further develop your complement pipeline.

LNP Characterization & Analytical Development Summit
2023-09-12 - 2023-09-14 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Fingerprinting Your LNP Drug Product Quality, Safety, Efficacy & Regulatory Compliance
With the recent breakthroughs from Verve Therapeutics, Vertex-Arbor Bio, and Mana.bio propelling the field of LNP technology forward at lightning speed beyond mRNA vaccines, the LNP Characterization & Analytical Development Summit is your must-attend meeting to deep dive into the latest technologies and approaches throughout product lifecycle and strengthen your lipid nanoparticle characterization, bioanalytical and assay development competencies.
With unmissable case studies from the likes of Pfizer, Moderna, AstraZeneca, Ultranegyx, Merck and SINTEF, this is the definitive forum to benchmark and learn with the LNP community who unite for the first time.
These industry titans have collaborated to form a comprehensive, 3-day program covering key topics including:

Analyze LNP structure and morphology to relay into functional data and analytical practices with Ultragenyx and Pfizer
Optimize the characterization of payloads to foresee the outcome of the LNP complex with Hopewell Therapeutics, Beam Therapeutics and Moderna
Develop assays which align with mechanisms of action and portray total functionality of the LNP with NIST, Editas Medicine and AstraZeneca

Don’t miss this opportunity to supercharge your analytics, and together with 60+ characterization and analytical scientists, get inspiration to derive best practice, and support next generation of therapeutics to patients with safety and efficacy.
To know more visit: https://ter.li/z7dmih

3rd Rare & Genetic Kidney Disease Drug Development Summit
2023-09-12 - 2023-09-14 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Your one-stop shop to capturing industry’s most exciting developments to tackle rare & genetic kidney diseases. From evaluating real-world outcomes to uncovering underlying pathophysiology to interrogating translational models, the 3rd Rare & Genetic Kidney Disease Drug Development Summit is uniquely positioned to give industry the opportunity to unite towards a shared goal and share strategic insights to move from bench to bedside and bring efficacious therapies to patients faster.
To know more visit: https://ter.li/jy2ot0

Wearable Injectors and Connected Devices USA
2023-09-13 - 2023-09-14 | Sheraton Boston Hotel, 39 Dalton Street, Boston, MA, 02199, United States
Wearable Injectors and Connected Devices USA
Conference: September, 13 – 14 2023
Boston, USA
Website: http://www.wearableinjectors-usa.com/PharmaJournalist-EL
Advancing digital health and on-body drug delivery devices for enhanced patient experience
Following the success of the Wearable Injectors and Connected Devices Europe conference, SAE Media Group will be bringing the conference to Boston to cater to Big Pharma, Biotech and Device Developers in the USA.
As the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows, on-body injectors and connected devices hold great opportunity. The conference will delve into on-body device design and development, latest advances in connectivity and digital integration of wearable devices, and opportunities for enhancement of user-interface through human factors case studies. The conference will also address challenges in regulations surrounding wearable injectors and connected devices with case studies and an FDA keynote on cybersecurity.
As part of SAE Media Group’s leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in September 2023!
Key Reasons to Attend:

Discover the latest advances in wearable injector design and development as well as emerging technologies for improved drug delivery
Understand and gain insight into the regulations surrounding electronic devices and wearable injectors such as labelling requirements and clinical study expectations
Delve into the digital integration of medical devices for improved user experience and strategies to ensure connected ecosystems are safe with an FDA Cybersecurity update
Benchmark against connected injector case studies and gain insight into key considerations during development such as battery selection
Engage in the latest strategies for implementing user centricity into device design to meet patient needs and increase adherence

WHO SHOULD ATTEND?
Device Developers
Combination Product Developers
Smart Packaging Developers and Designers
Smart Device Developers
Drug- Delivery Developers
Connected/Digital Health Developers

7th IPF Summit
2023-09-19 - 2023-09-21 | Westin Boston Seaport, 425 Summer Street, Boston, MA, 02210, United States
FIbroGen’s recent Phase 3 trial failure for pamrevlumab exemplifies the critical time point the pulmonary fibrosis field is currently at as drug developers move through in-human to Phase 2 to Phase 3 trials to get the next disease-modifying drug to the patients in need.
The 7th IPF Summit (September 19-21 | Boston) returns at this crucial stage for the drug development and academic communities to come together to address R&D bottlenecks, troubleshoot key discovery challenges, and share exclusive data to accelerate the latest ideas and innovations in the IPF field and supercharge a new era of IPF therapeutics.
If you haven’t yet seen the line-up of 42+ expert speakers, take a look at the full program in the event guide!
Are you looking to address and solve challenges with IPF therapeutic development, such as:

Understanding cell cross-talk in the lung pathobiology of IPF, including epithelial and endothelial cells
Harnessing precision medicine for IPF including patient selectivity, combinational therapies, and biomarkers
Whether to incorporate imaging into your preclinical and clinical development and the potential of using imaging as an endpoint in IPF?

Then this is the event for you! This is your unique opportunity to leverage knowledge from world-leading IPF industry experts and KOL academics on the latest developments to overcome, discovery, preclinical, translational, and clinical, challenges of IPF therapeutic development for successful advancement of therapeutic candidates to in-human studies and beyond.
Join experts from the likes of Boehringer Ingelheim, Genentech, Pfizer, AstraZeneca, BMS, Pliant, Galecto, Vicore, Avalyn, Pieris, Moderna, Takeda and more who have already saved their places at the meeting.
See pricing and registration options here!

2nd mRNA Process Development & Manufacturing Summit
2023-09-26 - 2023-09-28 | Boston Convention and Exhibition Center (BCEC), 415 Summer Street, Boston, MA, MA 02210, United States
Returning to Boston as the world’s only industry-leading meeting focused on mRNA process development and manufacturing, join 200+ VPs, Directors and Heads of Process Development, MSAT, Technical Operations, CMC and more from large pharma, innovative biotechs, and academia.
Download the program here: https://ter.li/5o4hdl
This must-attend meeting will provide you with technical insight and know-how from the largest process development and manufacturing speaker faculty to date, enabling you to revolutionize your processes for effective industrialization.
Spanning three tracks dedicated to Research Scale, IND-Enabling & Clinical Scale, and Commercial Scale, this year’s meeting will dive deep into the challenges, requirements, innovations and opportunities to improve your design, development and scale-up solutions from drug substance to drug product for regulatory and market readiness.
Register here: https://ter.li/nu15iq

5th TIL Therapies Summit
2023-10-02 - 2023-10-04 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
With the first commercial TIL therapy brewing at Iovance, along with various clinical readouts which are set to come to fruition in 2023, the race is on for the next generation of modified TIL to enter the clinic.

Returning as the only forum to address bottlenecks in end-to-end TIL development, the 5th TIL Therapies Summit is designed exclusively for TIL experts to fast-track your program into the clinic and beyond.
Unite with this niche community across industry and academia as pioneers from Iovance Biotherapeutics, Turnstone Biologics, Achilles Therapeutics and Lyell Immunopharma share clinical updates, next-gen engineering, and novel innovations to turbocharge preclinical and clinical development of safe, scalable and effective TIL therapies.
With 23+ expert speakers, 8 new companies and a brand-new Manufacturing & Characterization Bootcamp, you won’t want to miss this unrivalled opportunity to connect and collaborate with industry leaders.
Don’t let your team get left behind! Join us as we accelerate the next wave of TIL therapies into the clinic and beyond. Find out more – https://ter.li/mk23q3.

Wearable Injectors and Connected Devices Conference & Expo
2023-10-09 - 2023-10-10 | Hilton London Kensington, 179-199 Holland Park Ave, London, W11 4UL, United Kingdom
Wearable Injectors and Connected Devices Conference & Expo
9 – 10 October 2023 | London, UK
http://www.wearable-injectors.co.uk/PharmaJournalist-EL
Strategies to advance digital health and on-body drug devices for large volume delivery
SAE Media Group are proud to announce the 4th annual Wearable Injectors and Connected Devices conference. As the need for at home self-administration and routes for delivery of time-dependent and high-volume drug delivery grows, on-body injectors and connected devices hold great opportunity.
The conference will delve into on-body device design and development, enhancing digital connectivity for injectable devices, strategic approaches to wearable device design, regulatory considerations and primary container considerations for large volume delivery systems.
As part of SAE Media Group’s leading Injectable series of conferences, we bring together high-level experts from big pharma and device developers to network and share knowledge to advance R&D. The two-day conference will not only bring you high-quality key insights needed to enhance your wearable devices and connected product portfolio but will also give you the opportunity to network with key players throughout the industry. We hope to welcome you to this must attend event in October 2023!
Benefits of Attending:

Engage with key regulatory updates surrounding digital health and medical devices
Discover advances in device design and development for large volume delivery via on-body injectors
Explore the key drivers of novel drug products for the development for on-body injectors
Hear insights into the growing potential of digital health to improve patient experience and treatment
Develop your understanding of design strategies for connectivity and digital health

Delegates will have the opportunity to network with the following companies:

Johnson & Johnson
Biogen
AstraZeneca
Merck KGaA
Novartis
Novo Nordisk
Boehringer Ingelheim

And many more!!
Who Should Attend:

Executives, Directors, VPs, Heads, Principals, Managers of:
Drug-Delivery Developers
Autoinjectors
Device Engineering
Human Factors
Injectables
Packaging
Regulatory Affairs
Connectivity
Medical Device Data
Novel Product Technology
Smart Device Developers
Device Safety Solution Providers
or anyone who works with Wearable Devices/ On-Body Injectors within pharmaceuticals, biotech, device developers and solution providers.

The two-day conference will bring you high-quality insights and industry connections on the latest advances in wearable injectors and connectivity, and a platform for exchanging ideas.

6th Neuropsychiatric Drug Development Summit
2023-10-10 - 2023-10-12 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
The Definitive Industry Forum for Spearheading Non-Psychedelic & Psychedelic R&D
2023 is booming with novel psychiatric R&D and the promise of precision medicine for neuropsychiatric patients. Pipelines are gaining momentum, with notable approvals on the horizon, as unmet needs in PTSD, bipolar, anxiety, schizophrenia, depression, and ADHD become greater and greater. There is, therefore, a huge deal of novel and promising research to be discussed this October at the 6th Neuropsychiatric Drug Development Summit.
With discovery, preclinical, translational, and clinical scientists from the likes of Biogen, Otsuka, AbbVie, Genentech, Lundbeck, Delix Therapeutics, Atai, Gilgamesh, and Cerevel Therapeutics, don’t miss the field’s favorite conference, specifically dedicated to biopharma’s most pressing challenges of de-risking the translational gap and advancing transformative neuropsychiatric candidates through the clinic.
To know more visit: https://ter.li/sar413

14th World ADC San Diego 2023
2023-10-16 - 2023-10-19 | Sheraton San Diego Hotel and Marina, 1380 Harbor Island Dr, San Diego, CA, 92101, United States
The ADC renaissance shows no sign of slowing down with the ground-breaking approval of ELAHERE for platinum resistant ovarian cancer, Pfizer’s jaw-dropping acquisition of Seagen for $43 billion, and BMS’ $1 billion+ pact with Tubulis. There has been no better time to reunite the World ADC community and invest in progressing ADCs to front line treatments for patients.
The highly anticipated 14th World ADC San Diego (October 16-19, 2023 | San Diego, CA) returns as the world’s largest industry-dedicated discussion and networking forum addressing and overcoming the challenges in end-to-end ADC development.
Gain exclusive access to the full event guide to view the full agenda with 120+ industry-leading speakers.
Whether you’re new to the field or an ADC guru, there is something for everyone included in this year’s agenda. Some of your must-attend talks per track include:

Discovery Chemistry: Join Christopher Marvin, Principal Research Scientist, AbbVie as he reviews the design and optimization of glucocorticoid receptor modulator payloads for Immunology ADCs
Cellular Biology: Discuss with Robert Lawrence, Principal Scientist, Seagen the influence of artificial intelligence on ADC target discovery
Translational: Review a best-in-class translational study with Meijuan Li, Vice President, Head of Translational Sciences & Biostatistics, Eisai Oncology
Clinical Lessons: Be the first to hear industry-changing clinical results from ImmunoGen, Byondis, Iksuda Therapeutics, Seagen, Bliss Bio, Genentech and Elucidia Oncology
Process and Analytical Development: Debate the key considerations for ADC comparability studies in a dedicated roundtable lead by ADC CMC expert, Julie Beaudet, CMC Staff Scientist, Regeneron Pharmaceuticals
Manufacturing and Supply Chain: Explore the manufacturing of novel dolaLock ADCs with supply chain architecture with Engin Ayturk, Executive Director, CMC Process Development, Mersana Therapeutics

Access to the complete agenda here including a 7-tracked seminar day and 10 industry-beating workshops.
Don’t miss out on the chance to reunite with the antibody-drug conjugate community while reflecting on the exciting year that ADCs have had, and building momentum for the future of this innovative field.

2nd Operationalise: Early Access Programmes Europe Summit
2023-10-16 - 2023-10-18 | Hilton Canary Wharf, South Quay, Marsh Wall, London, E14 9SH, United Kingdom
The Early Access Programmes Summit Europe returns for a second year this October, aiming to help the industry navigate the notoriously complex European regulatory landscape, and conquer operational hurdles to provide patients in Europe with early access to medicines.

This meeting provides a forum to address burning questions and share ideas on topics such as European regulatory guidelines, labelling, supply, and best practices around reimbursement, integrating of pre- and post-trial access programmes and scoping.
Providing practical, valuable case studies is this year’s expert speaker lineup including the likes of GlaxoSmithKline, Roche, Novartis, Sanofi, and many others! Visit our website to download a free copy of the full event guide to explore the jam-packed 3-day agenda and full speaker faculty.
Whether you’re a veteran at managing early access programmes and are looking to expand your geo, or a new entrant to the field, you’ll leave this conference with the practical lessons and essential connections needed to supercharge your European early access programme across 2023 and beyond.
To know more visit: https://bit.ly/3K4BpqO

4th Commercializing Flow Chemistry Summit
2023-10-16 - 2023-10-18 | Hilton Boston Back Bay, 40 Dalton St, Boston, MA, 02115, United States
Scaling Flow Chemistry for Sustainability, Safety and Speed to Market
With the growing demand for better flow technology, the 4th Commercializing Flow Chemistry Summit is your must-attend meeting to deep-dive into transforming your process efficiency, emerging technology toolbox and economic gains through strategic flow chemistry.
With unmissable case studies from the likes of Novartis, Boehringer Ingelheim, Sanofi, AbbVie, Eli Lilly and Takeda, this is the definitive forum to benchmark and learn with this forward-thinking community who reunite once more.
These industry titans have collaborated to form a comprehensive, 3-day program covering key topics including:

Elevate Sustainability with Industry Leaders: Join forces with Merck, Eli Lilly and AbbVie to integrate sustainable practices seamlessly into your workflow, enhancing both environmental responsibility and operational excellence
Unlock Efficiency through Automation: Discover the power of automation in flow chemistry, following the footsteps of efficiency leaders like Sanofi, Takeda, and Boehringer Ingelheim, and optimize your processes for peak performance
Master Multi-Step Techniques: Gain expert insights from Boehringer Ingelheim on handling multi-step reactions in both flow and batch setups, fine-tuning your manufacturing processes for maximum efficiency and output

Don’t miss this opportunity to streamline your continuous chemistry research into scaled commercial applications, and together with 80+ process chemists, engineers, and modellers, go beyond reaction to work up optimization to develop winning processes quicker and expedite your drug development.
To know more visit: https://ter.li/jfxs1m

2nd Innate Killer Summit Europe 2023
2023-10-17 - 2023-10-19 | Crowne Plaza London, Royal Victoria Dock, Western Gateway, London, E16 1AL, United Kingdom
The 2nd Innate Killer Europe Summit will gather 80+ key European Gamma Delta T, NK, iNKT, neutrophil, and macrophage developers in October to chase the holy grail of efficacious, off-the-shelf, solid tumour immunotherapies through effective and scalable engineering, engager and combination strategies that promote safe, potent and persistent innate immune therapies following application.
Don’t miss this chance to network with innate immune trailblazers from the likes of Sanofi, Takeda, Lift Biosciences, Mink Therapeutics, Affimed, Carisma Therapeutics, Arovella Therapeutics and receive 3-days of some of the best scientific and data driven case studies that will help propel your innate immune therapy into the clinic and beyond. Learn more – https://ter.li/nkcwg3

11th IMPACCT: Real World Evidence Summit 2023
2023-10-23 - 2023-10-25 | Hilton Boston Logan Airport, One Hotel Dr, Boston, MA, 02128, United States
Returning for its 11th year, the IMPACCT: Real World Evidence Summit 2023 will deep dive into the use of RWE for regulatory submissions and clinical trial innovation to unlock unstructured healthcare data and transform disease treatment.
Join 100+ senior leaders in RWE, RWD, real world analytics & epidemiologists from pharma and biotech to take part in this three-day summit with over 18 hours of exclusive content.
Don’t miss your unique opportunity to explore how to leverage RWE to target patient populations and drive DE&I into trials. For more information go to: https://ter.li/db1xte

Biosensors for Medical Wearables Conference and Expo
2023-10-23 - 2023-10-24 | COURTYARD BY MARRIOTT BOSTON DOWNTOWN, 275 Tremont St, Boston, MA, 02116, United States
Biosensors for Medical Wearables Conference and Expo
*In collaboration with Medical Design Briefs*
October 23-24, 2023 | Boston, MA, USA
http://www.biosensors-medical-wear.com/PharmaJournalist-WL
SAE Media Group’s 3rd Annual Biosensors for Medical Wearables Conference will be back for 2023 in Boston to bring together device developers, MedTech, component manufacturers and big pharma to share and discuss the exciting advances in the medical wearable technology landscape.
The wearable biosensors market has grown significantly in recent years leading to increasingly growing potential for medical applications and at home alternatives for patients. With growing applications and potential in remote patient monitoring, diagnosis, therapeutics and detection of disease, wearable sensors are attracting considerable interest due to their opportunities in better supporting patients, clinical outcomes and decisions. Furthermore, AI and connected technologies are furthering the potential opportunities of this industry. However, challenges including flexibility of wearable devices, the collection of clinical-grade data and advanced battery technologies still remain for the industry to overcome. This year’s conference looks to address these hot topics through case studies and industry insights.
This is a must attend event, giving you the chance to engage in the latest innovations that are accelerating the wearable biosensors industry. We hope to welcome you in October 2023!
Reasons to attend:

Benchmark against and explore the latest biosensor technologies for wearable medical devices from Abbott, Empatica and Hexoskin
Delve into the potential of wearable sensors and digital tools in decentralized diagnosis including a Johnson & Johnson case study on the Heartline project
Learn how game changing companies such as Philips and Medtronic are utilizing wearables to maximize remote patient monitoring opportunities for wider patient populations
Explore how AI and machine learning technologies are enabling optimized data collection and streamlined data analysis
Discover cutting-edge biosensor therapeutic applications for neurology with Neurasantys and a panel discussion on future medical opportunities

Who you can meet?

Andreas Caduff, Strategic Advisory Board, DiME
Lorelie Villarete, Manager, Clinical Affairs, Lingo Sensing Technology Unlimited Company (an Abbott Company)
Tim Callahan, VP Scientific Affairs, Philips
Kara Chappie, Director and Project Lead, Pfizer
Jason Case, Vice President, Research and Development, Patient Monitoring, Medtronic
James Mault, MD, Founder and CEO, BioIntellisense, Inc.
Jasmin Imsirovic, Associate Director, Takeda
Janet Nikolovski, New Venture Lead – Genitourinary Oncology, Johnson & Johnson
